Upcoming Events
Search Result For "Discovery".
- Event Type
- Event Category
- Event Country
- Event Date
Event Type
Categories
Country
City
Date
One of the most pivotal gatherings of your industry peers is happening soon and now's the time to get ahead of your competitors. CPHI Middle East i...
As innovative drug delivery platforms beyond GalNac continue to emerge and novel chemical modifications are discovered, the potential for RNAi ther...
With GSK's €1.4Bn investment into acquiring CureVac's infectious disease pipeline, Moderna and BioNTech's initiation of personalised cancer vacci...
Making Strides in Targeting PARP, ATR, ATM, WEE1 and POLθ AstraZeneca and Merck are at the forefront of DDR inhibitor development, focusing on ...
The CRISPR AgBio industry is approaching a key turning point. Numerous product concepts are awaiting approval from the USDA, the European Union is ...
Propel Kinase Biology Understanding to Increase Selectivity, Overcome Resistance and Find the Optimal Combination Partner to Develop Best and First...
Proteomics offers huge advantages for the discovery and pre-clinical development of small molecule drugs and their translation into robust clinical...
Accelerate collaboration and partnering across neurology and psychiatry pipelines and technologies, to reduce risk, validate technologies, and deli...
The radiopharmaceutical race is on and pharma leaders such as AstraZenca, BMS , Eli Lilly, Novartis and Sanofi are not getting left behind. Bolster...
2024 has revitalized the bacteriophage field, with over $9 Million invested into BiomX and Locus Bioscience; $24 Million dedicated by BARDA to prog...
Welcome to the 4th Novel Conjugates Summit! We are witnessing a surging 83% growth of novel drug conjugates, with major collaborations between N...
2024 was pivotal for TCR therapies. Following the commercial approval for Adaptimmune's Tecelra, positive clinical readouts, and FIH trials from Im...
Loading More...
